By rapidly establishing reperfusion, percutaneous transluminal coronary angioplasty (PTCA) can have a beneficial effect in patients with cardiogenic shock. In several series, PTCA was associated with survival to hospital discharge of approximately 60%. Unresolved issues relate to the management of patients with multivessel disease, the role of concomitant thrombolytic therapy, and the use of mechanical support devices.
|Original language||English (US)|
|State||Published - Jan 1 1992|
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine